
Disclaimer: We share general wellness education for people who want to learn more about the body’s natural systems and emerging science. This content is for informational purposes only and is not medical advice.
The Endocannabinoid System (ECS) is a recently discovered natural signaling system found throughout the body. Many researchers describe it as a “regulatory” network because it helps the body maintain balance (homeostasis)—the ongoing process of keeping internal systems steady as conditions change.
In simple terms, the ECS is the way the body “checks in,” sends messages, and fine-tunes activity across many normal, everyday processes. It does this through brief chemical signals, receptor “receivers,” and enzymes that help clear signals once they’re no longer needed.
1) Endocannabinoids (messengers your body makes)
Your body produces its own cannabinoid-like molecules/hormones— called endocannabinoids. Two of the most studied are anandamide (AEA) and 2-AG. These act as critical hormone messengers that are made when needed and then broken down.
2) Receptors (the receivers on cells)
Receptors are structures on or within cells that respond to chemical signals. Two of the most studied ECS-related receptors are:
3) Enzymes (the reset / clean-up crew)
Enzymes help break down endocannabinoids after they’ve done their job. This “on-demand” signaling—made when needed, cleared when done—is part of how the ECS supports balance over time.
The ECS is often discussed through the lens of CB1 and CB2 because they’re two of the most studied receptors in cannabinoid science.
This page is for general education only. It is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease.

The CB2 receptor is one of the most studied receptors connected to the Endocannabinoid System (ECS). While CB1 is strongly associated with activity in the brain and nervous system, CB2 receptors are found widely throughout the body, including on many cell types involved in immune signaling and how the body responds to everyday stressors.
You can think of CB2 as part of the body’s “balance and communication” network—one of the ways the body helps coordinate steady, appropriate responses over time.
Where is CB2 found?
CB2 receptors have been identified across many tissues and cell types. Researchers often highlight CB2 in connection with:
Immune cells and immune signaling
Peripheral tissues (outside the brain)
Whole-body regulation as part of the ECS
Because CB2 is not a driver of THC’s CB1 psychoactive (“high”) effects, CB2 is frequently discussed in wellness education as a pathway that can be engaged without intoxication/psychoactivity.
What does CB2 do (in plain language)?
In research and education, CB2 is commonly described as supporting the body’s ability to:
Communicate and regulate responses in a balanced way
Maintain homeostasis as conditions change
Fine-tune signaling in systems connected to immune activity
This is why many people interested in cannabinoid science pay attention to CB2—especially those who want to understand cannabinoid biology beyond CB1/THC intoxication.
A helpful reminder
CB2 is an area of active scientific study. While research is expanding, this page is for general education only.
Important: This content is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease.

CB1 and CB2 are both part of cannabinoid science, but they’re often discussed for different reasons. Understanding the difference can help people make sense of why “cannabinoid” conversations can sound so different depending on the product, the goal, and the context.
1) Where they’re commonly found
CB1 is strongly associated with the brain and nervous system, and it’s one of the reasons cannabinoid effects can feel noticeable in mood, perception, or coordination.
CB2 is widely distributed across many tissues and cell types throughout the body, and it’s often highlighted in connection with immune signaling and whole-body regulation.
2) Psychoactivity vs non-intoxicating pathways
The “high” from THC is largely linked to CB1 activity. That doesn’t mean CB1 is “bad”—it just means CB1 is more closely connected to effects that can feel psychoactive or impairing for some people.
CB2 is not a driver of THC’s psychoactive effects, which is why CB2 is frequently discussed in educational settings as part of non-intoxicating/nonpsychoactive cannabinoid biology.
3) What people often mean when they say “CB2-focused”
When someone says “CB2-focused,” they typically mean they’re interested in cannabinoid science that emphasizes:
* balance and regulation (homeostasis)
* whole-body systems rather than intoxication
* non-impairing/non-psychoactive approaches
A steady, grounded takeaway
CB1 and CB2 aren’t “either/or”—they’re part of a wider system. The key is clarity: CB1 is more closely tied to psychoactive THC effects, while
CB2 is often discussed as a non-intoxicating pathway connected to broader ECS body signaling.
Important: This content is for general education only. It is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease.
If you’d like to go deeper, here are trusted, science-forward starting points on the Endocannabinoid System (ECS), CB1/CB2 receptors, and endocannabinoid signaling. We recommend reading primary reviews and reference databases first, then branching into more specialized topics.
Note: These resources are provided for general education only and are not medical advice.
IUPHAR/BPS Guide to Pharmacology — Cannabinoid receptors (family overview)
https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=13
IUPHAR/BPS Guide to Pharmacology — CB1 receptor (reference page)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=56
IUPHAR/BPS Guide to Pharmacology — CB2 receptor (reference page)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=57
NIH / PubMed Central — “CB1 & CB2 Receptor Pharmacology” (review)
https://pmc.ncbi.nlm.nih.gov/articles/PMC5812699/
NIH / PubMed Central — “The endocannabinoid system: an overview” (review)
https://pmc.ncbi.nlm.nih.gov/articles/PMC3303140/
NIH / PubMed Central — “Cannabinoid Receptors: An Update…” (review)
https://pmc.ncbi.nlm.nih.gov/articles/PMC7590033/
NIH / PubMed Central — “Emerging Role of the CB2 Cannabinoid Receptor in Immune…” (review)
Copyright © 2025 Faith and Moon - All Rights Reserved.
The statements made on this website have not been evaluated by the FDA and the products here are not intended to diagnose, treat, cure, or prevent any disease. Please consult a physician or healthcare professional before using any of these products especially if you have pre-existing conditions or are pregnant/nursing.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.